搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
15 小时
RBC维持Ideaya Biosciences目标价,看好daro前景
RBC Capital维持Ideaya Biosciences (NASDAQ:IDYA)的"跑赢大市"评级和61.00美元的目标价。该公司的立场是在审查了公司最近关于其药物候选者darolutamide (daro)监管路径的更新后做出的,特别是考虑到积极的二期数据以及FDA对注册试验设计和终点的认可。
10 天
TROPION-Lung01 研究 CNS 数据出炉,ORR 提升超 2 倍,夯实 Dato-DXd 肺癌脑 ...
临床中,非小细胞肺癌(NSCLC)患者易于发生脑转移,可对患者生存和生活质量均产生显著不利影响,目前针对脑转移的有效治疗手段有限。新型治疗药物的出现不断改变着 NSCLC 的治疗格局,其中 TROP2 抗体偶联药物(ADC)Datopotamab Deruxtecan(Dato-DXd)不仅在有或无可靶向基因组改变(AGA)肺癌中显示出良好全身疗效,也为脑转移患者带来治疗新希望。 当地时间 9 月 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Would-be assassin charged
Gets 2-yrs for role in fraud
Diagnosed with Parkinson's
Phoenix breaks heat record
Woman dies in 'suicide pod’
Contempt charge coming?
‘Trump Train’ jury verdict
Food packaging cancer risk
Outlaws guitarist dies
Severe obesity on the rise
Executed by lethal injection
NC sending absentee ballots
Haitian group files complaint
To shut down TikTok Music
Retiring after 14 seasons
Study about oceans' acidity
Conn. counterfeit drug bust
Consumer confidence falls
Recalls 41K+ motorcycles
X account hacked
Dali owner, operator sued
Partners with Google
1st NL East title since 2011
EEOC blocked on rules
Helene forms in Caribbean
Foreign incentives offer?
PA county ballot ruling
Rioter mistakenly released
ISR: Hezbollah leader killed
Calls for US to lift sanctions
反馈